DrugPatentWatch Database Preview
Profile for United States of America Patent: 2015265591
US Patent Family Members and Approved Drugs for United States of America Patent: 2015265591
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Apr 27, 2027 | Celgene | REVLIMID | lenalidomide |
➤ Sign Up | Oct 7, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Sign Up | Nov 24, 2024 | Celgene | REVLIMID | lenalidomide |
➤ Sign Up | Oct 7, 2023 | Celgene | REVLIMID | lenalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |